Panic Disorders Market Growth Opportunities: Insights from 2025–2029

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

How Does The Market Size Of The Panic Disorders Industry Compare Between 2025 And 2029?

The panic disorders market size has experienced consistent expansion in recent years. Projections indicate it will grow from $10.73 billion in 2024 to $11.15 billion in 2025, achieving a compound annual growth rate (CAGR) of 3.9%. The historical period’s growth can be attributed to factors such as antidepressant medications, heightened mental health awareness, increased stress levels, greater access to mental health services, and advancements in diagnostic criteria.

The panic disorders market is anticipated to show significant expansion in the coming years. It is predicted to reach $13.97 billion by 2029, growing at a compound annual growth rate (CAGR) of 5.8%. This projected increase is driven by factors such as emerging pharmacological treatments, the availability of telepsychiatry services, increased attention to comorbidities, global mental health initiatives, the use of pharmacogenomics in treatment, and various public education programs. Key trends for the forecast period include the rise of digital mental health interventions, the application of telemedicine for panic disorder treatment, continuous innovations in medications, advancements in neurobiological research, and the adoption of remote monitoring and wearable technology.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13191&type=smp

Which Drivers Are Shaping The Panic Disorders Industry’s Market Share?

The rising number of psychiatric patients is anticipated to stimulate the expansion of the panic disorder market moving forward. Psychiatric patients are individuals grappling with mental illnesses that can disrupt cognitive functions, emotional states, and social behavior, often resulting in panic disorder or panic attacks characterized by their sudden and intense nature. Managing panic disorder in these patients typically involves a combination of therapeutic strategies, pharmaceutical interventions, and lifestyle adjustments designed to alleviate the symptoms of panic attacks, enhance their overall quality of life, and enable them to effectively cope with and manage their condition. As an illustration, in October 2022, the State of Mental Health in America 2022 report, issued by Mental Health America, a US-based non-profit focused on mental health, noted an increase in adults with any mental illnesses to 49,564,000, representing 19.86% of the total US population in 2022, compared to 47,132,000, which represented 19.00% of the total US population in 2021. Consequently, this increase in psychiatric patients is set to drive the growth of the panic disorder market.

How Is The Panic Disorders Market Classified Into Different Segments?

The panic disordersmarket covered in this report is segmented –

1) By Type: Agoraphobia; Social Anxiety Disorder (SAD); Obsessive-Compulsive Disorder (OCD); Bipolar Disorder; Post-Traumatic Stress Disorder (PTSD); Major Depressive Disorder

2) By Treatment: Medication; Beta Blockers; Serotonin And Norepinephrine Reuptake Inhibitors (SNRIs); Benzodiazepines; Anti-Epilepsy; Other Treatments

3) By Route Of Administration: Oral; Parenteral; Other Routes Of Administrations

4) By End Use: Hospital Pharmacies; Retailer Pharmacies; Online Pharmacy Stores

Subsegments:

1) By Agoraphobia: Situational Agoraphobia; Non-Situational Agoraphobia

2) By Social Anxiety Disorder (SAD): Performance Anxiety; Generalized Social Anxiety

3) By Obsessive-Compulsive Disorder (OCD): Contamination OCD; Harm OCD; Checking OCD; Symmetry OCD

4) By Bipolar Disorder: Bipolar I Disorder; Bipolar II Disorder; Cyclothymic Disorder

5) By Post-Traumatic Stress Disorder (PTSD): Acute PTSD; Chronic PTSD; Complex PTSD

6) By Major Depressive Disorder: Recurrent Major Depressive Disorder; Single Episode Major Depressive Disorder

What Are The Major Trends Driving The Growth Of The Panic Disorders Market?

Leading companies in the panic disorder market are concentrating on creating advanced medications, such as extended-release capsules, to maintain their market presence. Extended-release capsules are a type of drug that releases its active component slowly over time, typically for 12 or 24 hours, addressing conditions that necessitate medication for an extended duration. For example, in May 2023, Granules India Ltd., a pharmaceutical company based in India, obtained abbreviated new drug application (ANDA) approval from the US Food & Drug Administration (USFDA) for its Venlafaxine hydrochloride extended-release capsules. This product has proven bioequivalence to the reference-listed drug product (RLD), Effexor XR Extended-Release Capsules, manufactured by Upjohn US 2 LLC. Venlafaxine HCl extended-release capsules are prescribed for the treatment of conditions such as generalized anxiety disorder (GAD), major depressive disorder (MDD), panic disorder (PD), and social anxiety disorder (SAD). They function by elevating serotonin and norepinephrine levels in the brain, with a typical starting dosage of 75 mg per day, which a doctor may adjust as necessary.

Who Are The Top Performing Companies In The Panic Disorders Market In Recent Years?

Major companies operating in the panic disorders market report are F. Hoffmann-La Roche Ltd., Sanofi S.A, Bristol-Myers Squibb Company, AstraZeneca PLC, Abbott Laboratories, GlaxoSmithKline PLC, Eli Lilly and Company, Boehringer Ingelheim International GmbH., Baxter Inc., Teva Pharmaceutical Industries Ltd., Mylan N.V., Pfizer Inc., Sun Pharmaceutical Industries Ltd., Bausch Health Companies Inc., H. Lundbeck A/S, Shionogi & Co Ltd., Recordati S.p.A, Neurocrine Biosciences Inc., Neuraxpharm, Actavis Plc., Noven Pharmaceuticals Inc., Sumitomo Pharma Co. Ltd., VistaGen Therapeutics, Valeant Pharmaceuticals International Inc., LIFECARE NEURO PRODUCTS LTD.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/panic-disorders-global-market-report

Which Region Is Expected To Witness The Fastest Growth In The Panic Disorders Market?

North America was the largest region in the panic disorders market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the panic disorders market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request A Customized Version Of The Panic Disorders Market Report:

https://www.thebusinessresearchcompany.com/customise?id=13191&type=smp

Browse Through More Reports Similar to the Global Panic Disorders Market 2025, By The Business Research Company

Progressive Multifocal Leukoencephalopathy Treatment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/progressive-multifocal-leukoencephalopathy-treatment-global-market-report

Merkel Cell Carcinoma Treatment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/merkel-cell-carcinoma-treatment-global-market-report

Basal Cell Carcinoma Treatment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/basal-cell-carcinoma-treatment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795